ANTICUERPOS ANTI-PMEL 17 Y CONJUGADOS DE LOS MISMOS
La presente solicitud describe anticuerpos anti-PMEL 17, fragmentos de unión a antígeno de los mismos, y conjugados de anticuerpo fármaco de dichos anticuerpos o fragmentos de unión a antígeno conjugados a un inhibidor de GNAQ/GNA11. Además, se describe un proceso de preparación de anticuerpos, frag...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | D'Alessio, Joseph Anthony Robles, Eusebio Manchado Fleming, Tony Burger, Matthew Rauniyar, Vivek |
| description | La presente solicitud describe anticuerpos anti-PMEL 17, fragmentos de unión a antígeno de los mismos, y conjugados de anticuerpo fármaco de dichos anticuerpos o fragmentos de unión a antígeno conjugados a un inhibidor de GNAQ/GNA11. Además, se describe un proceso de preparación de anticuerpos, fragmentos de unión a antígeno, y conjugados de anticuerpo fármaco.
This application discloses anti-PMEL17 antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor. The invention also relates to methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CU20210047A7</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CU20210047A7</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CU20210047A73</originalsourceid><addsrcrecordid>eNrjZDB29AvxdA51DQrwD1YAsXUDfF19FAzNFSIVnP39vELdHV2AMi6uCj5Aytcz2Nc_mIeBNS0xpziVF0pzMyi6uYY4e-imFuTHpxYXJCan5qWWxDuHGhkYGRoYmJg7mhsTowYAf4Emxw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTICUERPOS ANTI-PMEL 17 Y CONJUGADOS DE LOS MISMOS</title><source>esp@cenet</source><creator>D'Alessio, Joseph Anthony ; Robles, Eusebio Manchado ; Fleming, Tony ; Burger, Matthew ; Rauniyar, Vivek</creator><creatorcontrib>D'Alessio, Joseph Anthony ; Robles, Eusebio Manchado ; Fleming, Tony ; Burger, Matthew ; Rauniyar, Vivek</creatorcontrib><description>La presente solicitud describe anticuerpos anti-PMEL 17, fragmentos de unión a antígeno de los mismos, y conjugados de anticuerpo fármaco de dichos anticuerpos o fragmentos de unión a antígeno conjugados a un inhibidor de GNAQ/GNA11. Además, se describe un proceso de preparación de anticuerpos, fragmentos de unión a antígeno, y conjugados de anticuerpo fármaco.
This application discloses anti-PMEL17 antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor. The invention also relates to methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.</description><language>spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220113&DB=EPODOC&CC=CU&NR=20210047A7$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220113&DB=EPODOC&CC=CU&NR=20210047A7$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>D'Alessio, Joseph Anthony</creatorcontrib><creatorcontrib>Robles, Eusebio Manchado</creatorcontrib><creatorcontrib>Fleming, Tony</creatorcontrib><creatorcontrib>Burger, Matthew</creatorcontrib><creatorcontrib>Rauniyar, Vivek</creatorcontrib><title>ANTICUERPOS ANTI-PMEL 17 Y CONJUGADOS DE LOS MISMOS</title><description>La presente solicitud describe anticuerpos anti-PMEL 17, fragmentos de unión a antígeno de los mismos, y conjugados de anticuerpo fármaco de dichos anticuerpos o fragmentos de unión a antígeno conjugados a un inhibidor de GNAQ/GNA11. Además, se describe un proceso de preparación de anticuerpos, fragmentos de unión a antígeno, y conjugados de anticuerpo fármaco.
This application discloses anti-PMEL17 antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor. The invention also relates to methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB29AvxdA51DQrwD1YAsXUDfF19FAzNFSIVnP39vELdHV2AMi6uCj5Aytcz2Nc_mIeBNS0xpziVF0pzMyi6uYY4e-imFuTHpxYXJCan5qWWxDuHGhkYGRoYmJg7mhsTowYAf4Emxw</recordid><startdate>20220113</startdate><enddate>20220113</enddate><creator>D'Alessio, Joseph Anthony</creator><creator>Robles, Eusebio Manchado</creator><creator>Fleming, Tony</creator><creator>Burger, Matthew</creator><creator>Rauniyar, Vivek</creator><scope>EVB</scope></search><sort><creationdate>20220113</creationdate><title>ANTICUERPOS ANTI-PMEL 17 Y CONJUGADOS DE LOS MISMOS</title><author>D'Alessio, Joseph Anthony ; Robles, Eusebio Manchado ; Fleming, Tony ; Burger, Matthew ; Rauniyar, Vivek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CU20210047A73</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>D'Alessio, Joseph Anthony</creatorcontrib><creatorcontrib>Robles, Eusebio Manchado</creatorcontrib><creatorcontrib>Fleming, Tony</creatorcontrib><creatorcontrib>Burger, Matthew</creatorcontrib><creatorcontrib>Rauniyar, Vivek</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>D'Alessio, Joseph Anthony</au><au>Robles, Eusebio Manchado</au><au>Fleming, Tony</au><au>Burger, Matthew</au><au>Rauniyar, Vivek</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTICUERPOS ANTI-PMEL 17 Y CONJUGADOS DE LOS MISMOS</title><date>2022-01-13</date><risdate>2022</risdate><abstract>La presente solicitud describe anticuerpos anti-PMEL 17, fragmentos de unión a antígeno de los mismos, y conjugados de anticuerpo fármaco de dichos anticuerpos o fragmentos de unión a antígeno conjugados a un inhibidor de GNAQ/GNA11. Además, se describe un proceso de preparación de anticuerpos, fragmentos de unión a antígeno, y conjugados de anticuerpo fármaco.
This application discloses anti-PMEL17 antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor. The invention also relates to methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_CU20210047A7 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | ANTICUERPOS ANTI-PMEL 17 Y CONJUGADOS DE LOS MISMOS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T00%3A28%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=D'Alessio,%20Joseph%20Anthony&rft.date=2022-01-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECU20210047A7%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |